drug
AB-1015
Phase 1updated 5mo agoby Arsenal Biosciences Inc
Phase 1community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying AB-1015
News(1)
- ArsenalBio sacrifices ‘majority’ of staff in pivot to in vivo CAR TAfter downsizing by 50% last year, Arsenal Biosciences is again laying off employees. This time, 99 people are getting cut as part of a strategic shift to focus the company’s R&D efforts on in vivo…biospace · 25d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that